MORPHINE SULFATE
FOR USE ONLY WHEN FENTANYL ON SHORTAGE

ACTION:  Analgesic
•  Centrally acting opiate analgesic effective for acute pain.
•  For cardiac patients:  morphine reduces the pain of ischemia and reduces anxiety, reducing

oxygen demands on the heart, improving ischemia.

INDICATIONS:
•  Chest pain of suspected ischemic origin.
•  Management of acute pain according to ALS Treatment Protocols.

CONTRAINDICATIONS:
•  Hypersensitivity
•  Respiratory Insufficiency
•  Asthma or exacerbated COPD

POTENTIAL SIDE EFFECTS:
•  Respiratory depression
•  Hypotension
•  Decreased LOC

•  Head injury
•  Hypotension
•  Decreased LOC

•  Nausea and vomiting
•  Decreased heart rate

ADULT DOSE/ROUTE:
➔  2 - 4 mg slow IVP/IO or 5mg IM. May repeat in 10min for continued pain if SBP > 90 mmHg

to total dose of 20 mg.

PEDIATRIC DOSE/ROUTE:
➔  Less than 6 months: 0.05mg/kg slow IVP/IM/IO. May repeat in 10min at half the initial

dose. Max dose 4mg without Base Contact.

➔  Greater than 6 months: 0.1 mg/kg slow IVP/IM/IO. May repeat in 10min at half the initial

dose x1. Max dose 4mg without Base Contact.

NOTES:
•  When used in conjunction with non-narcotic pain medications, such as Ibuprofen and

Ketorolac, Morphine may be used in doses smaller than those listed above for
adults/pediatrics and repeated to reach desired effect (not to exceed max dose).
•  Closely monitor respiratory status and systolic blood pressure. Be prepared to assist

ventilations of any patient who is administered Morphine.

•  Morphine effects may be potentiated if administered with midazolam.  Contact Base

Hospital Physician if considering administering both medications.

•  Contact Base Hospital Physician if higher doses of Morphine are required.

1

Effective: 10/1/25
Supersedes: 10/01/21

